SPECIAL NOTICE
65 -- Hologic Panther Analyzer HPV Testing Supplies
- Notice Date
- 12/5/2023 11:00:11 AM
- Notice Type
- Special Notice
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- DEFENSE HEALTH AGENCY FALLS CHURCH VA 22042 USA
- ZIP Code
- 22042
- Response Due
- 1/5/2024 12:30:00 PM
- Archive Date
- 01/05/2024
- Point of Contact
- Jessica Horst
- E-Mail Address
-
jessica.l.horst5.civ@health.mil
(jessica.l.horst5.civ@health.mil)
- Description
- The Defense Health Agency (DHA) Southeast Contracting Division intends to negotiate a modification to a contract on a sole source basis (IAW FAR 13.501(a) sole source acquisitions). The proposed source is Hologic Sales and Service, LLC; Cage Code: 5JP89 located at 250 Campus Drive Marlborough, MA 01752. It is the contractor�s responsibility to be familiar with the applicable FAR and DFARS clauses and provisions.� The FAR and DFARS clauses may be accessed in full text at the below-referenced addresses: FAR Clauses: http://acquisition.gov/browsefar DFARS Clauses: https://www.acq.osd.mil/dpap/dars/dfarspgi/current/ The requirement is supplies for HPV testing to operate specifically on the Hologic Panther Analyzer. The item numbers consist of PRD-303570, Aptima HPV Assay (100 test), PRD-303236 Aptima HPV 16 18/45 Genotype Assay (100 test), PRD-301154CAptima Specimen Transfer Kit (LPT) which are required for HPV real-time testing on the existing Hologic Panther analyzer.� Hologic is identified as the only company to provide HPV test supplies that are required for utilization on the Panther Analyzer. �The Assay test reagents, transfer kits are required to perform patient testing on the Hologic Panther analyzer.� The Aptima assays have been validated for use with the Panther system.� The firmware in the Panther system is necessary for running the Aptima assays and is unique to Hologic.� The kits and reagents were developed and qualified to be used with the Aptima assays and may include proprietary technology. There are no set-aside restrictions for this requirement.� The intended procurement will be classified under North America Industry Classification System (NAICS) 325413-In-Vitro Diagnostic Substance Manufacturing.� This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement.� However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product.� All capability statements received by the closing date of this synopsis will be considered by the Government.� A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government.� Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to April Gillespie at april.m.gillespie2.civ@health.mil and Jessica Horst at jessica.l.horst5.civ@health.mil. �Closing date for challenges is no later than 03:30 PM ET on 16 November 2023.� No phone calls will be accepted.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/9cc0ebbff70d4b77beee6f7e73cecef9/view)
- Place of Performance
- Address: Marlborough, MA 01752, USA
- Zip Code: 01752
- Country: USA
- Zip Code: 01752
- Record
- SN06902511-F 20231207/231205230046 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |